21. Real-world study on HR+, HER2−, node-positive, high-risk early breast cancer (EBC) in France: patient profiles, management and treatment patterns. (April 2021) Authors: Pivot, X.; Chartier, F.; Chouaki, N.; Brown, J.; Williams, R.; Rider, A. Journal: Breast Issue: Volume 56(2021)Supplement 1 Page Start: S37 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
22. Safety and tolerability of subcutaneous trastuzumab for the adjuvant treatment of human epidermal growth factor receptor 2-positive early breast cancer: SafeHer phase III study's primary analysis of 2573 patients. (September 2017) Authors: Gligorov, J.; Ataseven, B.; Verrill, M.; De Laurentiis, M.; Jung, K.H.; Azim, H.A.; Al-Sakaff, N.; Lauer, S.; Shing, M.; Pivot, X. Journal: European journal of cancer Issue: Volume 82(2017) Page Start: 237 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
23. SAT0412 Arthralgia Occurring under Aromatase Inhibitor Treatment for Breast Cancer. A Prospective Controlled Study. (23rd January 2014) Authors: Wendling, D.; Letho-Gyselinck, H.; Guillot, X.; Prati, C.; Pivot, X. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A722 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
24. The open-label, multinational, multicenter, Phase IIIB umbrella study of subcutaneous trastuzumab with or without chemotherapy or pertuzumab in patients (pts) with HER2-positive early breast cancer (EBC) or metastatic breast cancer (MBC): Pooled analysis of safety data from the UmbHER1 program. (April 2018) Authors: Pivot, X.; Poole, C.; Martín, M.; Gligorov, J.; Barrios, C.H.; Vrdoljak, E.; Zambetti, M.; Woodward, N.; Ten Tije, A.J.; Lindegger, N.; Crespel, G.; Truman, M.; Steger, G.G. Journal: European journal of cancer Issue: Volume 92(2018)Supplement 3 Page Start: S105 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗